Real-time enrollment status for this scapholunate advanced collapse (slac) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 10:59 AM UTC
| NCT Number | NCT05719935 |
| Recruiting Status | Recruiting |
| Condition | Scapholunate Advanced Collapse (SLAC) |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Extremity Medical |
| Last Updated on CT.gov | November 15, 2023 (Nov 15, 2023) |
As of July 13, 2026: Clinical trial NCT05719935 is currently recruiting participants. This clinical trial study for scapholunate advanced collapse (slac) is actively seeking new participants at 4 locations across the United States. The study is sponsored by Extremity Medical. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05719935 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05719935 was last updated Nov 15, 2023 (November 15, 2023). HelloStudys verifies this status automatically.